Unlock AI-driven, actionable R&D insights for your next breakthrough.

Metal Organic Framework Nanoparticles: Advanced Synthesis, Functionalization Strategies, And Emerging Applications In Biomedicine And Catalysis

MAR 27, 202658 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Metal organic framework nanoparticles (MOF nanoparticles) represent a transformative class of porous crystalline hybrid materials constructed through coordination bonds between metal ions or clusters and organic ligands. These nanoscale architectures exhibit exceptional tunability in pore size (typically 5–30 nm), surface area (1370–3500 m²/g), and chemical functionality, enabling applications spanning drug delivery, gene therapy, gas storage, catalysis, and environmental remediation 123. Recent advances in surface modification, morphology control, and composite engineering have positioned MOF nanoparticles as versatile platforms for addressing critical challenges in biomedical engineering and sustainable energy systems.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Composition And Structural Characteristics Of Metal Organic Framework Nanoparticles

Metal organic framework nanoparticles are hybrid organic-inorganic materials formed by self-assembly of metal nodes (ions or clusters) with multidentate organic ligands through coordination chemistry 38. The metal nodes commonly include transition metals such as zirconium (Zr), zinc (Zn), iron (Fe), copper (Cu), cobalt (Co), and nickel (Ni), while organic ligands range from carboxylates (e.g., terephthalic acid, trimesic acid) to nitrogen-containing heterocycles (e.g., imidazolates, triazolates) 21216. The coordination number between metal centers and ligands typically ranges from 6 to 12, with Zr-based MOFs forming stable Zr₆O₄(OH)₄ or Zr₆O₈(CO₂)₈ clusters that enable up to 12 coordination bonds 1014. This structural diversity allows precise control over pore architecture, with cavity dimensions spanning 0.9–30 nm depending on ligand length and metal cluster geometry 815.

The crystalline nature of MOF nanoparticles distinguishes them from amorphous coordination polymers, providing well-defined pore channels and predictable host-guest interactions 316. Zeolitic imidazolate frameworks (ZIFs), a prominent MOF subclass, consist of tetrahedral metal nodes (typically Zn²⁺ or Co²⁺) bridged by imidazolate ligands, yielding zeolite-like topologies with enhanced thermal and chemical stability 12. For instance, ZIF-8 (Zn(methylimidazolate)₂) exhibits a sodalite topology with pore apertures of approximately 3.4 Å and cage diameters of 11.6 Å, enabling size-selective molecular sieving 12. The BET specific surface area of individual MOF nanoparticles ranges from 1370 m²/g for nano-ZIFs to over 3500 m²/g for hierarchical MOF composites embedding smaller nanoparticles within larger frameworks 18.

Particle size control is critical for biomedical applications, where nanoparticles in the 5–300 nm range demonstrate optimal cellular uptake and biodistribution 817. Ultra-small MOF nanoparticles (2–10 nm) synthesized via solvothermal methods using ethanol/o-dichlorobenzene mixed solvents exhibit high dispersibility and enhanced catalytic activity due to increased surface-to-volume ratios 17. Branched MOF nanoparticles with controlled morphology have been achieved through modulator-assisted synthesis, where chemical modulators (e.g., acetic acid, benzoic acid) compete with organic ligands during crystallization, directing anisotropic growth and producing dendritic or star-shaped architectures 1. These morphological variations influence diffusion kinetics, loading capacity, and release profiles in drug delivery systems.

Synthesis Methodologies And Morphology Engineering For Metal Organic Framework Nanoparticles

Solvothermal And Modulated Synthesis Routes

The predominant synthesis approach for MOF nanoparticles involves solvothermal reactions where metal precursors (e.g., Zn(NO₃)₂, Cu(O₂CCH₃)₂, ZrCl₄) and organic ligands are dissolved in polar aprotic solvents (dimethylformamide, N-methyl-2-pyrrolidone) or alcohols (methanol, ethanol) and heated at 60–150°C for 12–72 hours 3815. The reaction temperature, time, metal-to-ligand molar ratio (typically 1:1 to 1:4), and solvent composition critically determine particle size and crystallinity 1718. For example, synthesis of nano-ZIF-8 at 25°C in methanol yields 50–100 nm particles, whereas increasing temperature to 120°C produces micron-sized crystals 12.

Chemical modulators play a pivotal role in controlling MOF nanoparticle morphology by competing with bridging ligands for metal coordination sites, thereby modulating nucleation and growth rates 1. Monocarboxylic acids (acetic acid, formic acid) act as capping agents that preferentially bind to specific crystal facets, inducing anisotropic growth and generating branched or rod-like nanoparticles 1. The modulator concentration (typically 10–100 molar equivalents relative to metal precursor) and chain length influence the degree of branching and aspect ratio 1. This strategy has enabled synthesis of star-shaped UiO-66 (Zr-based MOF) nanoparticles with arm lengths of 50–200 nm, offering enhanced surface area for catalytic applications 1.

Composite And Hierarchical Architectures

Hierarchical MOF composites embedding functional nanoparticles within the framework matrix represent an advanced synthesis paradigm 4918. Plasmonic MOF nanoparticles incorporating gold nanobipyramids (AuBPs) within ZIF-8 matrices have been synthesized via sequential assembly, where pre-formed AuBPs (20–80 nm) are dispersed in a MOF precursor solution, followed by controlled crystallization around the plasmonic cores 4. The resulting composites exhibit localized surface plasmon resonance (LSPR) at 600–900 nm, enabling photothermal activation for ultrafast solvent desorption (complete desorption in <5 minutes under 808 nm laser irradiation at 1.5 W/cm²) and recyclable catalysis 4. The AuBP loading (0.15–5 vol%) can be tuned by adjusting the AuBP-to-MOF precursor ratio, with higher loadings enhancing photothermal efficiency but potentially compromising framework crystallinity 49.

Silica metal organic framework (SMOF) nanoparticles represent another composite class where organosilica networks (synthesized via sol-gel condensation of imidazolyl- or carboxyl-functionalized silanes) are integrated with MOF components 25. The organosilica matrix provides mechanical stability and pH-responsive degradation, while the MOF component (e.g., Zn-imidazolate or Fe-carboxylate) enables high-capacity loading of hydrophilic drugs, polynucleic acids, or proteins 25. SMOF nanoparticles (50–150 nm) exhibit pH-dependent disassembly, with rapid cargo release at acidic pH (5.0–6.0) due to protonation-induced metal-ligand bond cleavage, making them suitable for tumor-targeted delivery 25.

Surface Functionalization Via Post-Synthetic Modification

Post-synthetic modification (PSM) of MOF nanoparticle surfaces is essential for enhancing colloidal stability, biocompatibility, and targeting specificity 378. Polymer coating with polyethylene glycol (PEG) or polyzwitterions (e.g., poly(carboxybetaine)) via covalent conjugation to surface-exposed metal sites or ligands prevents aggregation and reduces non-specific protein adsorption 238. PEGylated UiO-66 nanoparticles (100 nm) coated with 5 kDa PEG chains exhibit prolonged circulation half-life (>12 hours) in mice compared to uncoated particles (<2 hours), attributed to reduced opsonization and macrophage uptake 38.

Oligonucleotide functionalization of MOF nanoparticles has been achieved through direct coordination of terminal phosphate groups to surface metal sites, forming stable metal-phosphate bonds 7. This strategy enables dense oligonucleotide loading (up to 200 strands per 100 nm particle) while preserving MOF porosity and structural integrity 7. Oligonucleotide-functionalized MOF nanoparticles serve as programmable gene delivery vectors, with sequence-specific targeting and stimuli-responsive release triggered by enzymatic cleavage or competitive displacement 7. Antibody conjugation to MOF surfaces via carbodiimide chemistry (EDC/NHS coupling) or click chemistry (azide-alkyne cycloaddition) imparts active targeting capabilities for cancer immunotherapy 1014. Zr-based MOF nanoparticles conjugated with anti-PD-L1 antibodies demonstrate 3-fold higher tumor accumulation and enhanced T-cell infiltration in murine melanoma models compared to non-targeted controls 1014.

Physicochemical Properties And Performance Metrics Of Metal Organic Framework Nanoparticles

Porosity, Surface Area, And Gas Adsorption Characteristics

The permanent porosity of MOF nanoparticles, characterized by nitrogen adsorption isotherms at 77 K, yields BET surface areas ranging from 1370 m²/g for compact nano-ZIFs to 3500 m²/g for hierarchical MOF-in-MOF composites 18. Pore size distributions, determined via density functional theory (DFT) analysis of adsorption data, reveal bimodal or trimodal pore architectures in composite systems, with micropores (0.5–2 nm) within individual MOF crystallites and mesopores (2–10 nm) at inter-particle interfaces 918. This hierarchical porosity enhances mass transport and guest molecule accessibility, critical for catalytic and separation applications.

Gas storage capacity is a key performance metric, with MOF nanoparticles achieving methane uptake of 200–250 cm³(STP)/g at 35 bar and 298 K, approaching the DOE target of 263 cm³(STP)/g for vehicular natural gas storage 1118. Incorporation of metal nanoparticles (Pd, Pt, Ni) within MOF pores via chemical reduction of metal precursors enhances hydrogen adsorption through spillover effects, increasing H₂ uptake by 30–50% relative to pristine MOFs 1119. For instance, Pd nanoparticles (2–5 nm) embedded in MOF-5 (Zn₄O(BDC)₃) elevate hydrogen storage capacity from 1.5 wt% to 2.1 wt% at 77 K and 1 bar 11.

Thermal And Chemical Stability Profiles

Thermal stability of MOF nanoparticles, assessed via thermogravimetric analysis (TGA), varies widely depending on metal-ligand bond strength and framework topology 3812. Zr-based MOFs (UiO-66, UiO-67) exhibit exceptional thermal stability, maintaining structural integrity up to 500°C in air due to strong Zr-O bonds (bond dissociation energy ~760 kJ/mol) 38. In contrast, Zn-imidazolate frameworks (ZIF-8) decompose at 350–400°C, while Cu-carboxylate MOFs (HKUST-1) degrade at 250–300°C 1218. Polymer-coated MOF nanoparticles demonstrate enhanced hydrolytic stability, with PEGylated UiO-66 retaining >90% crystallinity after 7 days in phosphate-buffered saline (pH 7.4, 37°C), compared to 60% for uncoated particles 38.

Chemical stability in acidic and basic media is critical for biomedical applications. Zr-MOFs exhibit remarkable acid resistance, showing negligible degradation in pH 2–3 solutions over 24 hours, whereas Zn-based MOFs rapidly dissolve under acidic conditions (pH <5) due to protonation-induced metal-ligand dissociation 258. This pH-responsive degradation is exploited in SMOF nanoparticles for triggered drug release in acidic tumor microenvironments (pH 5.5–6.5) 25. Alkaline stability is generally lower, with most MOFs undergoing ligand hydrolysis at pH >10, though Fe-carboxylate MOFs (MIL-100, MIL-101) maintain stability up to pH 12 25.

Optical And Electronic Properties In Functional Composites

Plasmonic MOF nanoparticles incorporating gold or silver nanostructures exhibit tunable optical absorption in the visible-to-near-infrared range (500–1000 nm), determined by the size, shape, and dielectric environment of the plasmonic component 4. Gold nanobipyramids (aspect ratio 3–5) embedded in ZIF-8 display LSPR peaks at 650–850 nm, with photothermal conversion efficiencies of 40–60% under resonant excitation 4. The MOF shell thickness (10–50 nm) modulates the LSPR wavelength via refractive index changes, enabling spectral tuning for specific photothermal or photocatalytic applications 4.

Redox-active MOF nanoparticles based on 1,2,3-triazolate ligands coordinated to Fe²⁺ or Co²⁺ exhibit reversible electrochemical behavior with formal potentials of -0.3 to +0.5 V vs. Ag/AgCl, suitable for energy storage and electrocatalysis 16. These nanoparticles (20–100 nm) demonstrate electrical conductivity of 10⁻⁴ to 10⁻² S/cm, orders of magnitude higher than insulating carboxylate-based MOFs, attributed to efficient electron hopping between redox-active metal centers 16. The polydispersity index (PDI) of triazolate MOF nanoparticles synthesized via controlled precipitation is <0.3, ensuring uniform electrochemical performance across particle populations 16.

Biomedical Applications Of Metal Organic Framework Nanoparticles

Drug Delivery Systems With Controlled Release Profiles

MOF nanoparticles serve as high-capacity drug carriers, with loading capacities of 20–60 wt% for small-molecule therapeutics (doxorubicin, camptothecin, 5-fluorouracil) achieved through physical encapsulation within pores or coordination to metal sites 3810. The drug loading mechanism depends on guest-host interactions: hydrophobic drugs partition into hydrophobic pores via van der Waals forces, while drugs with carboxylate or amine groups coordinate to unsaturated metal sites 38. For example, doxorubicin loading in UiO-66 nanoparticles reaches 45 wt% through π-π stacking with terephthalate ligands and coordination to Zr₆ clusters 38.

Release kinetics are governed by framework degradation, ligand exchange, or competitive displacement, enabling stimuli-responsive delivery 2358. pH-responsive SMOF nanoparticles loaded with doxorubicin exhibit <10% release at pH 7.4 over 48 hours, but >80% release at pH 5.5 within 12 hours, attributed to acid-catalyzed hydrolysis of Zn-imidazolate bonds 25. Polymer-coated MOF nanoparticles demonstrate zero-order release kinetics over 7–14 days, with release rates tunable by adjusting polymer molecular weight and coating thickness 38. In vivo studies in tumor-bearing mice show that PEGylated UiO-66 nanoparticles loaded with camptothecin achieve 2.5-fold higher tumor accumulation and 60% tumor growth inhibition compared to free drug, with minimal systemic toxicity 38.

Gene Therapy And Nucleic Acid Delivery Platforms

MOF nanoparticles address key challenges in gene delivery, including low transfection efficiency, serum instability, and immunogenicity of naked nucleic acids 2567. SMOF nanoparticles encapsulating plasmid DNA (pDNA) or messenger RNA (mRNA) protect cargo

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
MASSACHUSETTS INSTITUTE OF TECHNOLOGYCatalytic systems requiring high surface area and controlled diffusion kinetics, drug delivery systems with tunable release profiles.Branched MOF NanoparticlesControlled morphology and size through chemical modulator-assisted synthesis, enabling anisotropic growth with arm lengths of 50-200 nm and enhanced surface area for catalytic applications.
WISCONSIN ALUMNI RESEARCH FOUNDATIONTumor-targeted drug delivery, gene therapy in acidic tumor microenvironments, delivery of hydrophilic drugs and polynucleic acids.SMOF NanoparticlespH-responsive degradation with rapid cargo release at acidic pH (5.0-6.0), achieving >80% drug release within 12 hours at tumor pH while maintaining <10% release at physiological pH 7.4.
Cambridge Enterprise LimitedDrug delivery systems requiring extended shelf-life and controlled release, cancer therapeutics with enhanced biocompatibility and reduced opsonization.Polymer-Coated MOF NanoparticlesPEGylated UiO-66 nanoparticles with prolonged circulation half-life (>12 hours) and zero-order release kinetics over 7-14 days, achieving 2.5-fold higher tumor accumulation and 60% tumor growth inhibition.
B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. AT BEN-GURION UNIVERSITYPhotothermal-activated catalysis, ultrafast desorption processes, photocatalytic applications requiring tunable optical absorption in 650-850 nm range.Plasmonic MOF CompositesGold nanobipyramids embedded in ZIF-8 with photothermal conversion efficiency of 40-60%, enabling ultrafast solvent desorption (<5 minutes under 808 nm laser at 1.5 W/cm²) and recyclable catalysis.
NORTHWESTERN UNIVERSITYGene therapy and gene expression regulation, programmable drug delivery systems with stimuli-responsive release triggered by enzymatic cleavage.Oligonucleotide-Functionalized MOF NanoparticlesDense oligonucleotide loading (up to 200 strands per 100 nm particle) through metal-phosphate bonds while preserving MOF porosity and structural integrity, enabling programmable gene delivery with sequence-specific targeting.
Reference
  • Branched metal-organic framework nanoparticles and associated methods
    PatentWO2019241260A1
    View detail
  • Ph-responsive silica metal organic framework nanoparticles for delivery of bio active molecules
    PatentWO2020210367A1
    View detail
  • MOF nanoparticles
    PatentPendingUS20240050379A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png